ARS Pharmaceuticals (SPRY) Faces Securities Class Action Over CVS Caremark Formulary Delay
A securities class action has been filed on behalf of investors who purchased securities of ARS Pharmaceuticals Inc. (NASDAQ: SPRY) between March 9, 2026, and June 24, 2026. The lawsuit ... Read More